Literature DB >> 4947943

A double-blind study of azaribine in the treatment of psoriasis.

W R Vogler, S Olansky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4947943     DOI： 10.7326/0003-4819-73-6-951

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Azaribine (triacetyl-6-azauridine) in psoriasis. Screening by in vitro methods.

Authors:  W Raab; B Gmeiner; P Muckenhuber
Journal:  Arch Dermatol Res       Date:  1977-12-27       Impact factor: 3.017

Review 2.  Diseases of the skin. Psoriasis.

Authors:  L Stankier
Journal:  Br Med J       Date:  1974-01-05

Review 3.  New indications for 6-azauridine treatment in man. A review.

Authors:  J Elis; H Rasková
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

Review 4.  Research into psoriasis--the last decade.

Authors:  S Shuster
Journal:  Br Med J       Date:  1971-07-24

Review 5.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.